BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37771632)

  • 1. Progress in the research of cuproptosis and possible targets for cancer therapy.
    Wang J; Luo LZ; Liang DM; Guo C; Huang ZH; Sun GY; Wen J
    World J Clin Oncol; 2023 Sep; 14(9):324-334. PubMed ID: 37771632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cuproptosis mediates copper-induced testicular spermatogenic cell death.
    Zhang JY; Yu XJ; Li JJ; Xiao Y; Li GS; Yang F; Dong L
    Asian J Androl; 2024 Jan; 26(3):295-301. PubMed ID: 38284772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights.
    Abdullah KM; Kaushal JB; Takkar S; Sharma G; Alsafwani ZW; Pothuraju R; Batra SK; Siddiqui JA
    Heliyon; 2024 Mar; 10(5):e27496. PubMed ID: 38486750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of immune infiltration and cuproptosis-related subgroups in Crohn's disease.
    Yuan Y; Fu M; Li N; Ye M
    Front Immunol; 2022; 13():1074271. PubMed ID: 36466876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial-Targeted Copper Delivery for Cuproptosis-Based Synergistic Cancer Therapy.
    Deng J; Zhuang H; Shao S; Zeng X; Xue P; Bai T; Wang X; Shangguan S; Chen Y; Yan S; Huang W
    Adv Healthc Mater; 2024 Mar; ():e2304522. PubMed ID: 38530073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Molecular Subtyping Scheme Based on In Silico Analysis of Cuproptosis Regulator Gene Patterns Optimizes Survival Prediction and Treatment of Hepatocellular Carcinoma.
    Jiang H; Chen H; Wang Y; Qian Y
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
    Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
    Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review.
    Yuan HJ; Xue YT; Liu Y
    Cardiovasc Diagn Ther; 2022 Oct; 12(5):681-692. PubMed ID: 36329965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases.
    Ban XX; Wan H; Wan XX; Tan YT; Hu XM; Ban HX; Chen XY; Huang K; Zhang Q; Xiong K
    Curr Med Sci; 2024 Feb; 44(1):28-50. PubMed ID: 38336987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cuproptosis: mechanisms and links with cancers.
    Xie J; Yang Y; Gao Y; He J
    Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cuproptosis in understanding diseases.
    Cao S; Wang Q; Sun Z; Zhang Y; Liu Q; Huang Q; Ding G; Jia Z
    Hum Cell; 2023 Jul; 36(4):1244-1252. PubMed ID: 37154876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression.
    Zhao Q; Qi T
    Front Oncol; 2023; 13():1117164. PubMed ID: 36925927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy.
    Springer C; Humayun D; Skouta R
    Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cuproptosis-related genes score: A predictor for hepatocellular carcinoma prognosis, immunotherapy efficacy, and metabolic reprogramming.
    Nie G; Peng D; Wen N; Wang Y; Lu J; Li B
    Front Oncol; 2023; 13():1096351. PubMed ID: 36845733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and Future of "Turn-On" Based Small-Molecule Copper Probes for Cuproptosis.
    Peng TE; Qiu F; Qu Y; Yu C; Cheng X; Li L
    ChemistryOpen; 2023 Sep; 12(9):e202300078. PubMed ID: 37705070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of Cuproptosis Genes and Identification of Cuproptosis Subtypes in Breast Cancer.
    Li J; Li L; Dong Y; Zhong B; Yin W
    Comb Chem High Throughput Screen; 2023; 26(8):1578-1593. PubMed ID: 36683372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials.
    Wang J; Li J; Liu J; Chan KY; Lee HS; Lin KN; Wang CC; Lau TS
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper homeostasis and cuproptosis in health and disease.
    Chen L; Min J; Wang F
    Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cuproptosis-a potential target for the treatment of osteoporosis.
    Li D; Gao Z; Li Q; Liu X; Liu H
    Front Endocrinol (Lausanne); 2023; 14():1135181. PubMed ID: 37214253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer.
    Wang W; Lu K; Jiang X; Wei Q; Zhu L; Wang X; Jin H; Feng L
    J Exp Clin Cancer Res; 2023 Jun; 42(1):142. PubMed ID: 37277863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.